» Articles » PMID: 8257295

Sequence Analysis of Hepatitis B Virus DNA in Immunologically Negative Infection

Overview
Journal Arch Virol
Specialty Microbiology
Date 1993 Jan 1
PMID 8257295
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

It was previously demonstrated that the serum of some patients without immunological evidence of HBV infection contains the virus. Here we demonstrated by sequence analysis that the serum of such a patient contained a mixed HBV population. In comparison with HBV genomes of different genotypes twenty-two nucleotide variations were found in all clones sequenced in parallel. One nucleotide variation was identified within the enhancer I. Twelve of the twenty-two nucleotide variations caused altogether fifteen changes of amino acid sequence in known or predicted viral proteins. The proteins of the P open reading frame, which are most important for viral replication, were affected by nine amino acid substitutions. Three amino acid substitutions concerned the product of the X gene, a transcriptional transactivator of various viral and cellular promoters. Three mutations were only observed in some of the clones. One point mutation affected the direct repeats of the enhancer II. It occurred together with an 8 bp-deletion involving the C promoter region and the X gene. The third mutation was a single insertion, causing a fusion of the X and C gene. One or several of the identified mutations could be responsible for the diminished rate of replication and consequently for the low-titred, immunologically negative HBV infection.

Citing Articles

Mutations and methods of analysis of mutations in Hepatitis B virus.

Rajput M AIMS Microbiol. 2020; 6(4):401-421.

PMID: 33364535 PMC: 7755589. DOI: 10.3934/microbiol.2020024.


Comparative analysis of CpG islands among HBV genotypes.

Zhang Y, Li C, Zhang Y, Zhu H, Kang Y, Liu H PLoS One. 2013; 8(2):e56711.

PMID: 23451072 PMC: 3579858. DOI: 10.1371/journal.pone.0056711.


A mutation of the start codon in the X region of hepatitis B virus DNA in a patient with non-B, non-C chronic hepatitis.

Fujise K, Tatsuzawa K, Kono M, Hoshina S, Tsubota A, Niiya M World J Hepatol. 2011; 3(2):56-60.

PMID: 21423595 PMC: 3060996. DOI: 10.4254/wjh.v3.i2.56.


Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigen-negative subject.

Grethe S, Monazahian M, Bohme I, THOMSSEN R J Virol. 1998; 72(9):7692-6.

PMID: 9696878 PMC: 110046. DOI: 10.1128/JVI.72.9.7692-7696.1998.


Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease.

Gunther S, Piwon N, Iwanska A, Schilling R, Meisel H, Will H J Virol. 1996; 70(12):8318-31.

PMID: 8970951 PMC: 190919. DOI: 10.1128/JVI.70.12.8318-8331.1996.


References
1.
Honigwachs J, Faktor O, Dikstein R, Shaul Y, Laub O . Liver-specific expression of hepatitis B virus is determined by the combined action of the core gene promoter and the enhancer. J Virol. 1989; 63(2):919-24. PMC: 247766. DOI: 10.1128/JVI.63.2.919-924.1989. View

2.
Blum H, Zhang Z, Galun E, von Weizsacker F, Garner B, Liang T . Hepatitis B virus X protein is not central to the viral life cycle in vitro. J Virol. 1992; 66(2):1223-7. PMC: 240832. DOI: 10.1128/JVI.66.2.1223-1227.1992. View

3.
Radziwill G, Tucker W, Schaller H . Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J Virol. 1990; 64(2):613-20. PMC: 249151. DOI: 10.1128/JVI.64.2.613-620.1990. View

4.
Tong S, Li J, Vitvitski L, Trepo C . Active hepatitis B virus replication in the presence of anti-HBe is associated with viral variants containing an inactive pre-C region. Virology. 1990; 176(2):596-603. DOI: 10.1016/0042-6822(90)90030-u. View

5.
Thiers V, Nakajima E, Kremsdorf D, Mack D, Schellekens H, Driss F . Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet. 1988; 2(8623):1273-6. DOI: 10.1016/s0140-6736(88)92891-7. View